中华检验医学杂志
中華檢驗醫學雜誌
중화검험의학잡지
CHINESE JOURNAL OF LABORATORY MEDICINE
2015年
7期
484-486
,共3页
高岚%刘慧芳%凌明智%田文倩%赵明静%赵文心%许泼实
高嵐%劉慧芳%凌明智%田文倩%趙明靜%趙文心%許潑實
고람%류혜방%릉명지%전문천%조명정%조문심%허발실
癌,肝细胞%微RNAs%生物学标记%聚合酶链反应
癌,肝細胞%微RNAs%生物學標記%聚閤酶鏈反應
암,간세포%미RNAs%생물학표기%취합매련반응
Carcinoma,hepatocellular%microRNAs%Biological markers%Polymerase chain reaction
目的:探讨肝细胞肝癌患者血浆microRNA-21( miR-21)水平的变化及其临床意义。方法病例对照研究,采用实时荧光定量PCR检测河南省人民医院2014年1至6月收治的60例肝细胞肝癌( HCC)患者、71例肝硬化( LC)患者及52名健康体检者( HV)血浆miR-21表达量并计算miR-21相对表达量。通过分析受试者工作特征曲线( ROC)判断miR-21表达水平在肝癌诊断中的敏感度和特异度。两样本均数比较采用t检验。结果 HCC组患者血浆miR-21相对表达量(2.6±1.1)均高于LC组(1.6±0.9)和HV组(1.0±0.6),差异有统计学意义(HCC组与LC组比较t=5.322,P=0.004;HCC组与HV组比较t=8.349,P=0.0003)。 HCC患者血浆miR-21相对表达量与肿瘤分化和大小相关,差异有统计学意义(tdif =3.366,P=0.019;tsize =3.490,P=0.012),与TNM肿瘤分期、肿瘤数量、AFP浓度无相关,差异无统计学意义( tTNM =1.103,P=0.274;tnum =1.682,P=0.097;tAFP =1.756,P=0.084)。 ROC分析miR-21相对表达量在HCC组与HV组比较中敏感度为89.5%,特异度为81.8%,曲线下面积( AUC)为0.934;miR-21在HCC组与LC组比较中敏感度为70.0%,特异度为65.3%,AUC为0.796。结论肝细胞肝癌患者血浆中miR-21高表达,可能对肝细胞肝癌的临床诊断有意义。(中华检验医学杂志,2015,38:484-486)
目的:探討肝細胞肝癌患者血漿microRNA-21( miR-21)水平的變化及其臨床意義。方法病例對照研究,採用實時熒光定量PCR檢測河南省人民醫院2014年1至6月收治的60例肝細胞肝癌( HCC)患者、71例肝硬化( LC)患者及52名健康體檢者( HV)血漿miR-21錶達量併計算miR-21相對錶達量。通過分析受試者工作特徵麯線( ROC)判斷miR-21錶達水平在肝癌診斷中的敏感度和特異度。兩樣本均數比較採用t檢驗。結果 HCC組患者血漿miR-21相對錶達量(2.6±1.1)均高于LC組(1.6±0.9)和HV組(1.0±0.6),差異有統計學意義(HCC組與LC組比較t=5.322,P=0.004;HCC組與HV組比較t=8.349,P=0.0003)。 HCC患者血漿miR-21相對錶達量與腫瘤分化和大小相關,差異有統計學意義(tdif =3.366,P=0.019;tsize =3.490,P=0.012),與TNM腫瘤分期、腫瘤數量、AFP濃度無相關,差異無統計學意義( tTNM =1.103,P=0.274;tnum =1.682,P=0.097;tAFP =1.756,P=0.084)。 ROC分析miR-21相對錶達量在HCC組與HV組比較中敏感度為89.5%,特異度為81.8%,麯線下麵積( AUC)為0.934;miR-21在HCC組與LC組比較中敏感度為70.0%,特異度為65.3%,AUC為0.796。結論肝細胞肝癌患者血漿中miR-21高錶達,可能對肝細胞肝癌的臨床診斷有意義。(中華檢驗醫學雜誌,2015,38:484-486)
목적:탐토간세포간암환자혈장microRNA-21( miR-21)수평적변화급기림상의의。방법병례대조연구,채용실시형광정량PCR검측하남성인민의원2014년1지6월수치적60례간세포간암( HCC)환자、71례간경화( LC)환자급52명건강체검자( HV)혈장miR-21표체량병계산miR-21상대표체량。통과분석수시자공작특정곡선( ROC)판단miR-21표체수평재간암진단중적민감도화특이도。량양본균수비교채용t검험。결과 HCC조환자혈장miR-21상대표체량(2.6±1.1)균고우LC조(1.6±0.9)화HV조(1.0±0.6),차이유통계학의의(HCC조여LC조비교t=5.322,P=0.004;HCC조여HV조비교t=8.349,P=0.0003)。 HCC환자혈장miR-21상대표체량여종류분화화대소상관,차이유통계학의의(tdif =3.366,P=0.019;tsize =3.490,P=0.012),여TNM종류분기、종류수량、AFP농도무상관,차이무통계학의의( tTNM =1.103,P=0.274;tnum =1.682,P=0.097;tAFP =1.756,P=0.084)。 ROC분석miR-21상대표체량재HCC조여HV조비교중민감도위89.5%,특이도위81.8%,곡선하면적( AUC)위0.934;miR-21재HCC조여LC조비교중민감도위70.0%,특이도위65.3%,AUC위0.796。결론간세포간암환자혈장중miR-21고표체,가능대간세포간암적림상진단유의의。(중화검험의학잡지,2015,38:484-486)
Objective To evaluate the plasma level of miR-21 in hepatocellular carcinoma (HCC) patients and its clinical diagnostic significance .Methods Case-control study was used .The plasma level of miR-21 was measured by real-time quantitative PCR.The relative expressions of miR-21 were calculated. This study included 60 cases of patients with HCC , 71 patients with liver cirrhosis ( LC ) , 52 healthy volunteers ( HV) from January to June in 2014 in Henan Province People′s Hospital.The receiver operating characteristic ( ROC) curves were analyzed to determine the sensitivity and specificity of miR-21 expression levels in HCC diagnosis. Differences between groups were assessed by the t-test.Results Plasma microRNA-21 level in the 60 patients with hepatocellular carcinoma ( 2.6 ±1.1 ) was significantly higher than in patients with chronic hepatitis (1.6 ±0.9) and healthy volunteers (1.0 ±0.6) (t=5.322,P=0.004;t =8.349, P =0.000 3, respectively ) .Plasma microRNA-21 level in the HCC patients were positively correlated with tumor size and differentiation (tdif=3.366,P=0.019;tsize =3.490,P=0.012). ROC analysis of plasma microRNA-21 yielded an AUC of 0.796 with 70.0% sensitivity and 65.3%specificity when differentiating hepatocellular carcinoma from chronic hepatitis , and an AUC of 0.934 with 89.5% sensitivity and 81.8% specificity when differentiating hepatocellular carcinoma from healthy volunteers.Conclusion The plasma level of miR-21 in HCC patients has high specificity , and maybe help to diagnose of HCC.